-
Knowledge is pricelessBusiness Development& Licensing
Best practice in deal-making
Business Development & Licensing
Product Licensing
Companies have products that need further development or commercialisation support. A deal brings validation, resources and funding. Companies, large and small are in need of new products. The people responsible for deals are Business Development executives that coordinate the process until closing the deal. We help in identifying products for licensing, identifying corporate partners for licensing deals, strategic planning, preparation of materials for transactions.
Valuation
It is key in every deal to assess the value. This can only be substantiated if the appropriate projections are made, using industry-accepted principles. The sales of a product can be forecasted using assumptions from independent sources, projecting future cashflows. The cashflows are discounted to generate the Net Present Values which can also be risk-adjusted. Sensitivity analysis provides the range of the valuation. We are experts in Commercial Analysis and Financial Valuations.
Deal Structuring
Where Intellectual Property is typically the subject of a corporate deal, structuring a deal is complicated and the parties must agree numerous points including milestone payments, level of royalties, development, commercialisation efforts, territories, sharing IP, deal duration, termination and other provisions. A deal must be a win-win for both parties but it is during the negotiations that the value is created for the shareholders. Transactions and structuring deals are core to our expertise.
Due Diligence
Whether it's for an investment or for a corporate deal, due diligence is an integral part of the process. Due diligence is performed both commercially and technically. The technical due diligence includes patent checks, scientific data, competitive analysis, development plans, manufacturing, and other areas. Commercial due diligence is closely linked with financial and market analysis, sales and profit projections, sensitivity analysis with risk assumptions and valuations.
Alliance Management
Corporate deals take a long time to source, evaluate, negotiate and finalise and many fall through before being signed. Once a deal is put together though, its value to the company becomes often hundreds of millions and may also reach billions over its life time and when the alliance involves both parties working together, a high degree of co-ordination is necessary to avoid issues becoming problems in an alliance. The role of Alliance Management has become necessary.
New market launch
While relatively few large companies are truly global, many companies become successful in the marketing of their products in their home country or on a regional level, but are normally unable to develop their own infrastructure in other markets. We have a large network of links with licensees and distributors around the world which can facilitate geographical expansion and the introduction of novel healthcare products to new markets for companies that need to expand.
Partnerships are the key to success
We use best practice according to the pharmaceutical industry standards.
Importantly, our associates are from the specialized Business Development & Licensing function of the industry, we have our own proprietary research and best-practice “Deal Tools”, long experience with multinational companies, worldwide coverage, international culture and expertise, industry knowledge and thousands of personal contacts at senior level in the industry.
Our other services
Supporting Investors
We assist investors in independent due diligence, valuations, market forecasts, transactions and expert support in entering and exiting investments in the pharma and biotech sector.
Supporting law firms
We provide support in legal cases where there are disputes relating to Intellectual Property, Licensing Agreements, Commercialisation and other areas.
We focus on delivering results
Our team is comprised of industry professionals with lengthy experience in senior positions, augmented by a wide network of contacts in the pharma and biotech industry and the investment community. Our contribution is tailored to your specific needs.
Innovate. Create. Support. Deliver.
We are a Life Sciences advisory UK company based in London, assisting companies and investors in Pharma, Biotech, MedTech and HealthTech. We specialise in providing full-service support in Business Development & Licensing deals, Product Development, Financing, Commercialisation and Communications.
Core Areas
Quick Links
Contact Us
Address:
DyoDelta Biosciences Ltd
33 St James's Square
London SW1Y 4JS
U.K. Phone: +44 20 3239 3022
Email: enquiries @ dyodelta . com
[remove spaces between words]
© 2023 DyoDelta Biosciences Ltd . | All rights reserved. | Terms | Website Design by PharmaWebsites